Barbara Stella
- Biomaterials top 0.5%
- Nanoparticle-Based Drug Delivery 41
- Pharmaceutical Science top 0.5%
- Advanced Drug Delivery Systems 10
- Advancements in Transdermal Drug Delivery 5
- Molecular Medicine top 5%
- Biomedical Engineering top 2%
- Nanoplatforms for cancer theranostics 8
- Molecular Biology top 5%
- RNA Interference and Gene Delivery 25
- Advanced biosensing and bioanalysis techniques 7
-
- Proteoglycans and glycosaminoglycans research 9
-
- Cancer Treatment and Pharmacology 7
Barbara Stella
84 papers receiving 3.8k citations
Hit Papers
Peers
Comparison fields: 5 of 132
- Biomaterials 1.8k
- Pharmaceutical Science 565
- Molecular Medicine 151
- Biomedical Engineering 1.1k
- Molecular Biology 1.6k
Countries citing papers authored by Barbara Stella
This map shows the geographic impact of Barbara Stella's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barbara Stella with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barbara Stella more than expected).
Fields of papers citing papers by Barbara Stella
This network shows the impact of papers produced by Barbara Stella. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barbara Stella. The network helps show where Barbara Stella may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Barbara Stella, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 3 | |
| 3 | 2024 | 9 | |
| 4 | 2024 | 6 | |
| 5 | 2023 | 34 | |
| 6 | 2022 | 3 | |
| 7 | 2021 | 18 | |
| 8 | 2019 | 54 | |
| 9 | 2019 | 10 | |
| 10 | 2019 | 15 | |
| 11 | 2018 | 106 | |
| 12 | 2017 | 7 | |
| 13 | 2016 | 47 | |
| 14 | 2014 | 49 | |
| 15 | 2012 | 17 | |
| 16 | 2011 | 24 | |
| 17 | Reactors and strategies to control the particle size distribution of polymeric nanoparticles for pharmaceutical applications | 2008 | 1 |
| 18 | 2007 | 128 | |
| 19 | 2007 | 88 | |
| 20 | TRANSPLANTS AND NEUROTROPHINS INCREASE REGENERATION AND RECOVERY OF FUNCTION AFTER SPINAL CORD INJURY | 1997 | 1 |
About Barbara Stella
Barbara Stella is a scholar working on Biomaterials, Pharmaceutical Science and Cell Biology, having authored 86 papers that have together received 3.9k indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (41 papers), RNA Interference and Gene Delivery (25 papers), Advanced Drug Delivery Systems (10 papers), Proteoglycans and glycosaminoglycans research (9 papers), Nanoplatforms for cancer theranostics (8 papers), Cancer Treatment and Pharmacology (7 papers), Advanced biosensing and bioanalysis techniques (7 papers) and Advancements in Transdermal Drug Delivery (5 papers). The work is most often cited by research in Biomaterials (1.8k citations), Pharmaceutical Science (565 citations) and Molecular Medicine (151 citations). Barbara Stella has collaborated with scholars based in Italy, France and Belgium. Frequent co-authors include Silvia Arpicco, Franco Dosio, Luigi Cattel, Elias Fattal, Patrick Couvreur, Didier Desmaële, Paola Brusa, Véronique Marsaud, Jack‐Michel Renoir and Michel Renoir. Their work appears in journals such as International Journal of Pharmaceutics, Journal of Pharmaceutical Sciences, Bioconjugate Chemistry, Journal of Controlled Release and Journal of Drug Delivery Science and Technology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.